BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31352035)

  • 1. Diffusing Capacity of Carbon Monoxide in Assessment of COPD.
    Balasubramanian A; MacIntyre NR; Henderson RJ; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Make BJ; Wise RA; McCormack MC
    Chest; 2019 Dec; 156(6):1111-1119. PubMed ID: 31352035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D
    Choi J; Sim JK; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Rhee CK; Min KH
    BMC Pulm Med; 2021 May; 21(1):152. PubMed ID: 33957906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Carbon Monoxide Diffusing Capacity is the strongest lung function predictor of decline in 12 minute-walking distance in COPD; a 5-year follow-up study.
    Farkhooy A; Janson C; Arnardóttir RH; Emtner M; Hedenström H; Malinovschi A
    COPD; 2015 Jun; 12(3):240-8. PubMed ID: 25208266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
    Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
    Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
    J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusing capacity in chronic obstructive pulmonary disease assessment: A meta-analysis.
    Ni Y; Yu Y; Dai R; Shi G
    Chron Respir Dis; 2021; 18():14799731211056340. PubMed ID: 34855516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disproportionally Impaired Diffusion Capacity Relative to Airflow Limitation in COPD.
    Tanabe N; Rhee CK; Sato S; Muro S; Shima H; Tanimura K; Jung KS; Yoo KH; Hirai T
    COPD; 2020 Dec; 17(6):627-634. PubMed ID: 33222554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.
    Balasubramanian A; Putcha N; MacIntyre NR; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Regan E; Make BJ; Hansel NN; Wise RA; McCormack MC
    Ann Am Thorac Soc; 2023 Jan; 20(1):38-46. PubMed ID: 35969416
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired carbon monoxide diffusing capacity is the strongest predictor of exercise intolerance in COPD.
    Farkhooy A; Janson C; Arnardóttir RH; Malinovschi A; Emtner M; Hedenström H
    COPD; 2013 Apr; 10(2):180-5. PubMed ID: 23547629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection.
    Byanova KL; Fitzpatrick J; Jan AK; McGing M; Hartman-Filson M; Farr CK; Zhang M; Gardner K; Branchini J; Kerruish R; Bhide S; Bates A; Hsieh J; Abelman R; Hunt PW; Wang RJ; Crothers KA; Huang L
    PLoS One; 2023; 18(7):e0288803. PubMed ID: 37463173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.
    de-Torres JP; O'Donnell DE; Marín JM; Cabrera C; Casanova C; Marín M; Ezponda A; Cosio BG; Martinez C; Solanes I; Fuster A; Neder JA; Gonzalez-Gutierrez J; Celli BR
    Chest; 2021 Sep; 160(3):872-878. PubMed ID: 33901498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between steps of 6MWT and COPD severity: a cross-sectional study.
    Zeng GS; Chen LC; Fan HZ; Wu LL; Wu XP; Fang ZK; He X; Yu HP
    Int J Chron Obstruct Pulmon Dis; 2019; 14():141-148. PubMed ID: 30643400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: HIV Is Associated With Impaired Pulmonary Diffusing Capacity Independent of Emphysema.
    Raju S; Astemborski J; Drummond MB; Ramamurthi HC; Sun J; Brown RH; Kirk GD; McCormack MC
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):64-68. PubMed ID: 34560768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar-capillary reserve during exercise in patients with chronic obstructive pulmonary disease.
    Behnia M; Wheatley CM; Avolio A; Johnson BD
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3115-3122. PubMed ID: 29123389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.